FDA

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has chosen five groundbreaking technologies for its AI Airlock pilot, aimed at reshaping how AI-powered medical devices are regulated. This initiative is designed to facilitate the swift and safe introduction of […]

Novavax, Inc., an international leader in protein-based vaccines utilizing its Matrix-M adjuvant, has declared that it has secured a definitive transaction to divest its Bohumil, Czech Republic production site to Novo Nordisk for $200 million. The deal encompasses the transfer

Ono Pharmaceutical Co., Ltd. has revealed a strategic partnership agreement with Congruence Therapeutics, a cutting-edge biotechnology company based in Montreal, Canada. This collaboration focuses on developing new small molecule correctors targeting multiple protein pathways in the field of oncology, utilizing

Thryve Digital Health, renowned for delivering outstanding healthcare technology and operational services to major U.S. healthcare payers and providers, has been lauded with two significant accolades at the 2024 Indian CSR Awards in recognition of their exemplary contributions to Corporate

Astellas Pharma Canada, Inc. has announced Health Canada’s approval of Veozah (fezolinetant film-coated tablets) as the pioneering non-hormonal solution designed to address moderate to severe vasomotor symptoms related to menopause. As women transition through menopause, a phase that may dominate

The Drug Control Officers India Welfare Association (DCO India), representing both active and retired drug regulation officials nationwide, has called upon the Karnataka government to reassess the suspension of Dr. S Umesh, the state’s drug controller. This action followed reports

In a strategic move to boost India’s global pharmaceutical presence by tackling export-related challenges, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has extended an invitation to its members to point out obstacles and suggest inventive growth strategies. Underlining the

The Ministry of Health has elevated the importance of addressing snakebite incidents by designating it as a disease under the National Health Mission (NHM). This move requires all cases to be reported, enhancing surveillance and management efforts. By prioritizing snakebite

The Delhi High Court has prompted the central authority to contemplate a submission from the Center for Ichthyosis Related Members Foundation, an organization devoted to supporting individuals with Ichthyosis or those connected to them. The plea seeks recognition of Ichthyosis

Hansa Biopharma, an innovative commercial biopharmaceutical entity, together with Genethon, a leader in the sphere of gene therapy for rare genetic disorders, announced the launch of GNT-018-IDES. This is a phase 2 clinical trial aimed at individuals with Crigler-Najjar syndrome